Technical Analysis for LABP - Landos Biopharma, Inc.

Grade Last Price % Change Price Change
F 14.07 5.63% 0.75
LABP closed down 6.46 percent on Tuesday, February 23, 2021, on 52 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical LABP trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 5.63%
New 52 Week Closing High Bullish -2.97%
NR7 Range Contraction -2.97%
NR7-2 Range Contraction -2.97%
NR7 Range Contraction -1.40%
New 52 Week Closing High Bullish -1.95%
Hot IPO Pullback Bullish Swing Setup 2.03%
NR7 Range Contraction 2.03%
NR7-2 Range Contraction 2.03%
Hot IPO Pullback Bullish Swing Setup 8.23%
Older End-of-Day Signals for LABP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above 10 DMA about 1 hour ago
Up 5% about 1 hour ago
Gap Down Closed about 2 hours ago
60 Minute Opening Range Breakout about 2 hours ago
Hot IPO Pullback Entry about 2 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate in development is BT-11, an oral lanthionine synthetase C-like protein 2 (LANCL2) agonist for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and inflammatory bowel diseases. The company also develops NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1, a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and PX-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and rheumatoid arthritis. The company was founded in 2017 and is headquartered in Blacksburg, Virginia.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Autoimmune Diseases Rheumatoid Arthritis Gastroenterology Inflammatory Bowel Disease Colitis Ulcerative Colitis Diarrhea Abdominal Pain Diabetic Nephropathy Crohn's Disease Inflammatory Bowel Diseases

Is LABP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.35
52 Week Low 10.77
Average Volume 572,711
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 13.86
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.06
MACD Signal Line 0.02
MACD Histogram 0.0399
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.74
Resistance 3 (R3) 14.72 14.24 14.50
Resistance 2 (R2) 14.24 13.88 14.24 14.42
Resistance 1 (R1) 13.78 13.65 13.54 13.79 14.34
Pivot Point 13.29 13.29 13.17 13.30 13.29
Support 1 (S1) 12.83 12.93 12.59 12.85 12.30
Support 2 (S2) 12.35 12.71 12.35 12.22
Support 3 (S3) 11.89 12.35 12.14
Support 4 (S4) 11.90